Naveen Kumar Atray, MD
Nephrology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- Graduated 1994
Offices
1 location · Capital Nephrology Medical Group · 22 clinicians in this group
Hospitals listed: 052604 · 752534 · Sutter Davis Hospital · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Atray’s office at (916) 564-6232 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Davis HospitalDavis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Davis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 247 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.43 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 857 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,791 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.6 to 16.4) · 878 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 240 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$134,961
Medicare paid this office $134,961 for 404 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $30,019 | $238 |
| Home dialysis services per month (20 years or older) | 13 | $26,104 | $237 |
| Return visit (30+ min) | 144 | $15,946 | $63 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 67 | $12,687 | $184 |
| New patient visit (60+ min) | 25 | $3,831 | $153 |
See all 20 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $30,019 | $238 |
| Home dialysis services per month (20 years or older) | 13 | $26,104 | $237 |
| Return visit (30+ min) | 144 | $15,946 | $63 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 67 | $12,687 | $184 |
| New patient visit (60+ min) | 25 | $3,831 | $153 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $3,323 | $158 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 140 | $2,906 | $13 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | 13 | $2,841 | $219 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 24 | $2,622 | $52 |
| Long return visit (40+ min) | 26 | $2,505 | $89 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 21 | $2,446 | $111 |
| New patient visit (45+ min) | 21 | $2,262 | $108 |
| Short return visit (20+ min) | 41 | $2,057 | $49 |
| Critical care, first 30-74 minutes | 11 | $2,031 | $156 |
| Insertion of tube into chest or arm artery, each first order branch | 15 | $1,480 | $92 |
| Removal of tunneled central venous tube | 13 | $1,414 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,239 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $952 | $63 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 90 | $918 | $10 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $768 | $40 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 109 | 105 | 101 | 62 | 80 | 69 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 42 | 39 | 25 | 14 | 24 | 22 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 50 | 33 | 31 | 24 | 11 | – |
| Removal of tunneled central venous tube | 27 | 34 | 18 | 20 | 18 | 13 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 16 | 14 | 15 | – | – | – |
| Insertion of tube into chest or arm artery, each first order branch | – | – | – | – | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
404 Original Medicare patients in 2024. Average age 72 · Under 65 18% · 85 and older 11% · Women 51% · Also on Medicaid 63% · Health risk score 5.38. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 67% · Heart failure 48% · Coronary heart disease 44% · Atrial fibrillation 24% · Depression 23% · COPD 22% · Cancer 14% · Stroke 13% · Dementia 9%.
The office billed $359,300, Medicare allowed $179,938 and paid $134,961; for 1,797 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 404 | 1,797 | 72 | 5.38 | $359,300 | $134,961 |
| 2023 | 425 | 1,472 | 71 | 5.25 | $361,339 | $141,617 |
| 2022 | 435 | 1,438 | 71 | 5.00 | $442,109 | $173,408 |
| 2021 | 456 | 1,425 | 69 | 5.30 | $550,935 | $235,074 |
| 2020 | 515 | 1,762 | 69 | 5.51 | $587,520 | $216,700 |
| 2019 | 519 | 1,770 | 69 | 5.90 | $637,993 | $229,036 |
| 2018 | 534 | 2,276 | 68 | 6.04 | $859,049 | $257,417 |
| 2017 | 549 | 4,784 | 69 | 5.85 | $1,032,404 | $319,723 |
| 2016 | 511 | 5,886 | 68 | 5.63 | $1,662,776 | $564,190 |
| 2015 | 517 | 6,533 | 68 | 5.64 | $1,648,248 | $562,265 |
| 2014 | 562 | 38,262 | 67 | 5.68 | $1,966,554 | $688,025 |
| 2013 | 610 | 32,198 | 67 | 5.57 | $1,948,966 | $684,765 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $47,635 | $243 |
| Home dialysis services per month (20 years or older) | 17 | $21,443 | $244 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 74 | $15,296 | $191 |
| Return visit (30+ min) | 126 | $12,862 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $4,871 | $157 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 11 | $3,899 | $354 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $3,268 | $8 |
| Short return visit (20+ min) | 67 | $3,095 | $40 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 24 | $3,022 | $126 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | 13 | $2,889 | $222 |
| Removal of tunneled central venous tube | 17 | $1,917 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,844 | $66 |
| New patient visit (45+ min) | 15 | $1,693 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,684 | $99 |
| Long return visit (40+ min) | 18 | $1,675 | $93 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | $900 | $10 |
2022: 19 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 46 | $56,361 | $241 |
| Home dialysis services per month (20 years or older) | 14 | $20,331 | $245 |
| Return visit (30+ min) | 133 | $13,986 | $57 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 54 | $12,093 | $195 |
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $10,244 | $171 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 21 | $8,688 | $362 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $5,674 | $284 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | 20 | $4,436 | $222 |
| New patient visit (60+ min) | 25 | $4,116 | $165 |
| Short return visit (20+ min) | 54 | $3,154 | $56 |
| New patient visit (45+ min) | 19 | $2,453 | $129 |
| Removal of tunneled central venous tube | 20 | $2,279 | $114 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 14 | $1,854 | $132 |
| Replacement of tunneled central venous tube | 11 | $1,759 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,359 | $80 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 81 | $999 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $763 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $625 | $23 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $230 | $15 |
2021: 17 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 51 | $61,106 | $249 |
| Home dialysis services per month (20 years or older) | 24 | $46,720 | $247 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $27,526 | $299 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 91 | $19,771 | $196 |
| Return visit (30+ min) | 118 | $19,183 | $96 |
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $12,260 | $173 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 27 | $11,209 | $362 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $4,179 | $91 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 25 | $3,468 | $139 |
| New patient visit (60+ min) | 19 | $3,157 | $166 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 15 | $2,716 | $181 |
| Short return visit (20+ min) | 45 | $2,410 | $48 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | 11 | $2,396 | $218 |
| Removal of tunneled central venous tube | 18 | $1,911 | $106 |
| New patient visit (45+ min) | 17 | $1,611 | $95 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 120 | $1,520 | $10 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,159 | $58 |
2020: 16 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 53 | $60,548 | $203 |
| Home dialysis services per month (20 years or older) | 21 | $27,226 | $200 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $26,597 | $242 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 91 | $20,383 | $194 |
| Return visit (30+ min) | 123 | $15,119 | $76 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 28 | $11,900 | $361 |
| Dialysis services, 1 physician visit per month (20 years or older) | 42 | $11,837 | $158 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 38 | $4,857 | $125 |
| New patient visit (45+ min) | 32 | $3,934 | $123 |
| Removal of tunneled central venous tube | 34 | $3,768 | $111 |
| Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | 14 | $3,074 | $220 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 14 | $2,900 | $207 |
| New patient visit (60+ min) | 21 | $2,829 | $135 |
| Short return visit (20+ min) | 55 | $2,783 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 141 | $1,660 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 43 | $22 | $0 |
2019: 17 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 60 | $73,863 | $195 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 98 | $21,669 | $199 |
| Return visit (30+ min) | 132 | $18,703 | $80 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 39 | $18,518 | $370 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $15,155 | $233 |
| Dialysis services, 1 physician visit per month (20 years or older) | 41 | $12,891 | $152 |
| Home dialysis services per month (20 years or older) | 13 | $12,183 | $196 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 41 | $5,458 | $130 |
| New patient visit (60+ min) | 29 | $4,043 | $139 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 16 | $3,401 | $213 |
| Removal of tunneled central venous tube | 26 | $3,056 | $113 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 14 | $3,024 | $108 |
| Short return visit (20+ min) | 41 | $2,331 | $53 |
| New patient visit (45+ min) | 14 | $1,929 | $138 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 157 | $1,882 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $844 | $60 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $21 | $0 |
2018: 21 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 73 | $95,484 | $189 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 94 | $21,001 | $191 |
| Return visit (30+ min) | 125 | $17,428 | $78 |
| Dialysis services, 1 physician visit per month (20 years or older) | 51 | $15,935 | $149 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 32 | $13,988 | $359 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 12 | $13,845 | $1,065 |
| Home dialysis services per month (20 years or older) | 11 | $12,684 | $187 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $7,899 | $232 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 44 | $6,179 | $131 |
| New patient visit (60+ min) | 35 | $4,930 | $141 |
| Removal of tunneled central venous tube | 30 | $3,264 | $105 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 15 | $3,126 | $208 |
| Short return visit (20+ min) | 53 | $3,004 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $2,887 | $85 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 13 | $2,651 | $102 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 130 | $1,626 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $790 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 31 | $337 | $9 |
| Ultrasonic guidance for blood vessel access | 11 | $303 | $25 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17 | $36 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 14 | $6 | None |
2017: 27 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 72 | $56,099 | $191 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 23 | $51,712 | $1,915 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 45 | $51,654 | $1,013 |
| Return visit (30+ min) | 137 | $19,909 | $81 |
| Dialysis services, 1 physician visit per month (20 years or older) | 46 | $13,419 | $141 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 27 | $12,410 | $460 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 20 | $10,853 | $543 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 38 | $7,159 | $175 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $6,467 | $231 |
| Short return visit (20+ min) | 84 | $4,929 | $52 |
| Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | 14 | $4,829 | $345 |
| New patient visit (60+ min) | 21 | $3,516 | $167 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 73 | $3,472 | $43 |
| New patient visit (45+ min) | 23 | $2,568 | $112 |
| Removal of tunneled central venous tube | 21 | $2,559 | $122 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 13 | $2,418 | $105 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 15 | $1,759 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $996 | $59 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 12 | $854 | $71 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $569 | $10 |
| Ultrasonic guidance for blood vessel access | 16 | $421 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $381 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 23 | $260 | $9 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 55 | $257 | $0 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 95 | $190 | $0 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $158 | $9 |
| Injection, fentanyl citrate, 0.1 mg | 76 | $40 | None |
2016: 24 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 131 | $173,924 | $1,101 |
| Insertion of needle and/or catheter for dialysis | 178 | $100,013 | $465 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 38 | $63,736 | $1,416 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $30,164 | $192 |
| Insertion of tube into chest or arm artery, each first order branch | 42 | $27,321 | $569 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 127 | $18,073 | $117 |
| Return visit (30+ min) | 120 | $17,389 | $79 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 14 | $17,281 | $1,152 |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $13,913 | $145 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 21 | $11,988 | $571 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 42 | $10,975 | $224 |
| Replacement of tunneled central venous tube | 12 | $8,925 | $595 |
| Short return visit (20+ min) | 73 | $5,020 | $56 |
| Removal of tunneled central venous tube | 38 | $4,721 | $124 |
| New patient visit (45+ min) | 36 | $4,572 | $127 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 15 | $3,634 | $140 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 15 | $1,902 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,578 | $58 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 21 | $1,363 | $59 |
| Ultrasonic guidance for blood vessel access | 28 | $738 | $25 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 171 | $383 | $0 |
| Automated urinalysis test | 64 | $219 | $3 |
| Blood test, clotting time | 12 | $84 | $5 |
| Injection, fentanyl citrate, 0.1 mg | 136 | $63 | None |
2015: 23 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 124 | $170,575 | $1,080 |
| Insertion of needle and/or catheter for dialysis | 162 | $86,832 | $443 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 41 | $69,792 | $1,454 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $50,133 | $195 |
| Insertion of tube into chest or arm artery, each first order branch | 38 | $21,577 | $514 |
| Dialysis services, 1 physician visit per month (20 years or older) | 53 | $19,709 | $149 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 123 | $18,167 | $116 |
| Return visit (30+ min) | 114 | $15,115 | $78 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 26 | $14,595 | $561 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 42 | $10,946 | $223 |
| Replacement of tunneled central venous tube | 14 | $10,939 | $576 |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 16 | $5,437 | $170 |
| New patient visit (45+ min) | 38 | $4,986 | $131 |
| Short return visit (20+ min) | 72 | $4,785 | $53 |
| Removal of tunneled central venous tube | 24 | $2,980 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,409 | $59 |
| New patient visit (60+ min) | 12 | $2,002 | $167 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 31 | $1,903 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,862 | $85 |
| Ultrasonic guidance for blood vessel access | 30 | $802 | $27 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 154 | $437 | $0 |
| Blood test, clotting time | 13 | $89 | $5 |
| Injection, fentanyl citrate, 0.1 mg | 123 | $62 | None |
2014: 26 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 151 | $200,064 | $1,130 |
| Insertion of needle and/or catheter for dialysis | 195 | $101,606 | $448 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 60 | $67,674 | $192 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 38 | $59,273 | $1,446 |
| Insertion of tube into chest or arm artery, each first order branch | 41 | $23,821 | $529 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 148 | $21,383 | $122 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 33 | $18,841 | $571 |
| Dialysis services, 1 physician visit per month (20 years or older) | 49 | $18,677 | $151 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 45 | $17,258 | $1 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 12 | $16,801 | $1,292 |
| Return visit (30+ min) | 93 | $14,248 | $81 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 55 | $13,571 | $222 |
| Replacement of tunneled central venous tube | 19 | $10,382 | $519 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $8,063 | $202 |
| Removal of tunneled central venous tube | 46 | $5,609 | $117 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15 | $3,922 | None |
| New patient visit (45+ min) | 34 | $3,836 | $113 |
| Short return visit (20+ min) | 61 | $3,682 | $50 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 42 | $2,847 | $66 |
| Injection of drug or substance into vein | 45 | $2,635 | $45 |
| New patient visit (60+ min) | 17 | $2,448 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,454 | $58 |
| Ultrasonic guidance for blood vessel access | 34 | $1,021 | $30 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 182 | $573 | $0 |
| Injection of drug or substance into artery | 18 | $417 | $14 |
| Injection, fentanyl citrate, 0.1 mg | 143 | $68 | None |
2013: 30 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 144 | $196,229 | $1,148 |
| Insertion of needle and/or catheter for dialysis | 195 | $107,266 | $475 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 77 | $93,606 | $189 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 38 | $67,065 | $1,524 |
| Balloon dilation of narrowed or blocked upper arm artery, accessed through the skin | 17 | $22,127 | $1,302 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 140 | $21,470 | $129 |
| Insertion of tube into chest or arm artery, each first order branch | 34 | $20,863 | $580 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $16,595 | $224 |
| Dialysis services, 1 physician visit per month (20 years or older) | 53 | $14,641 | $146 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 45 | $12,318 | $232 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 38 | $11,962 | $1 |
| Replacement of tunneled central venous tube | 16 | $10,308 | $573 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 14 | $9,498 | $633 |
| Return visit (30+ min) | 67 | $8,127 | $77 |
| New patient visit (45+ min) | 48 | $5,855 | $122 |
| Removal of tunneled central venous tube | 46 | $5,716 | $122 |
| Short return visit (20+ min) | 89 | $5,353 | $51 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16 | $5,103 | None |
| Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) | 17 | $4,576 | $143 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 25 | $2,875 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $2,546 | $57 |
| Radiological supervision and interpretation of balloon dilation of narrowed artery | 16 | $2,079 | $130 |
| Injection of drug or substance into vein | 38 | $2,052 | $45 |
| New patient visit (60+ min) | 11 | $1,541 | $140 |
| Hemodialysis procedure with physician evaluation | 11 | $745 | $57 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 191 | $548 | $0 |
| Injection of drug or substance into artery | 16 | $468 | $17 |
| Ultrasonic guidance for blood vessel access | 16 | $452 | $27 |
| Short return visit | 11 | $324 | $29 |
| Injection, fentanyl citrate, 0.1 mg | 132 | $67 | None |
Medicaid work
$3,368 in 2024
Medicaid paid $3,368 for 285 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 127 | $2,373 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 134 | $976 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 24 | $19 |
| 2024 | 285 | 3 | 22 | $3,368 |
| 2023 | 328 | 2 | 25 | $2,221 |
| 2022 | 866 | 5 | 24 | $5,299 |
| 2021 | 2,831 | 6 | 22 | $6,198 |
| 2020 | 3,344 | 7 | 25 | $6,049 |
| 2019 | 2,672 | 5 | 24 | $8,502 |
| 2018 | 2,236 | 4 | 27 | $3,822 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 136 | $1,946 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 192 | $275 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 197 | $4,762 |
| Return visit (30+ min) | 66 | $511 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $14 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 16 | $13 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 575 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 137 | $4,308 |
| Return visit (30+ min) | 86 | $1,137 |
| INTRO CATH DIALYSIS CIRCUIT | 32 | $398 |
| Iron sucrose injection | 89 | $343 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 38 | $13 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,449 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 182 | $4,817 |
| Return visit (30+ min) | 147 | $574 |
| Iron sucrose injection | 86 | $450 |
| Injection, doxercalciferol, 1 mcg | 88 | $138 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $70 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 31 | $0 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,798 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 198 | $7,639 |
| Return visit (30+ min) | 148 | $653 |
| Iron sucrose injection | 47 | $145 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 55 | $65 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,224 | $0 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 90 | $2,888 |
| Return visit (30+ min) | 49 | $887 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 18 | $47 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 2,079 | $0 |
Drugs they prescribed that Part D paid
$446,718
Pharmacies billed $446,718 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,625) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,331 generic and fewer than 11 brand-name prescriptions · $446,718 in drug cost · 24 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lupkynis | 12 | $116,753 | $9,729 |
| Farxiga | 111 | $92,709 | $835 |
| Lokelma | 23 | $28,197 | $1,226 |
| Kerendia | 20 | $26,060 | $1,303 |
| Rayaldee | 18 | $22,924 | $1,274 |
See all 42 drugs
| Lupkynis | 12 | $116,753 | $9,729 |
| Farxiga | 111 | $92,709 | $835 |
| Lokelma | 23 | $28,197 | $1,226 |
| Kerendia | 20 | $26,060 | $1,303 |
| Rayaldee | 18 | $22,924 | $1,274 |
| Sevelamer Carbonate | 57 | $20,531 | $360 |
| Jardiance | 16 | $19,244 | $1,203 |
| Dapagliflozin | 12 | $7,196 | $600 |
| Clonidine | 36 | $4,810 | $134 |
| Calcium Acetate | 41 | $3,465 | $85 |
| Sps | 15 | $2,697 | $180 |
| Calcitriol | 151 | $2,286 | $15 |
| Febuxostat | 15 | $1,938 | $129 |
| Mycophenolate Mofetil | 17 | $1,706 | $100 |
| Sodium Polystyrene Sulfonate | 15 | $1,536 | $102 |
| Bumetanide | 50 | $1,522 | $30 |
| Tacrolimus | 17 | $1,319 | $78 |
| Irbesartan | 47 | $1,175 | $25 |
| Hydralazine | 34 | $1,129 | $33 |
| Losartan | 94 | $949 | $10 |
| Chlorthalidone | 42 | $861 | $20 |
| Furosemide | 108 | $798 | $7 |
| Carvedilol | 55 | $782 | $14 |
| Valsartan | 13 | $703 | $54 |
| Allopurinol | 67 | $644 | $10 |
| Potassium Chloride | 24 | $624 | $26 |
| Amlodipine Besylate | 72 | $586 | $8 |
| Lisinopril | 36 | $375 | $10 |
| Telmisartan | 12 | $337 | $28 |
| Colchicine | 11 | $323 | $29 |
| Spironolactone | 22 | $293 | $13 |
| Labetalol | 13 | $288 | $22 |
| Prednisone | 12 | $274 | $23 |
| Nifedipine Er | 14 | $195 | $14 |
| Tamsulosin | 29 | $149 | $5 |
| Gabapentin | 11 | $130 | $12 |
| Atorvastatin | 12 | $119 | $10 |
| Indapamide | 12 | $112 | $9 |
| Clonidine | 12 | $74 | $6 |
| Enalapril Maleate | 12 | $62 | $5 |
| Metoprolol | 16 | $50 | $3 |
| Pioglitazone | 12 | $38 | $3 |
Year by year
| 2024 | 1,625 | 255 | 0% (0) | None | $446,718 |
| 2023 | 1,581 | 259 | None | 14% | $365,034 |
| 2022 | 1,427 | 260 | None | None | $243,496 |
| 2021 | 1,460 | 231 | None | None | $265,373 |
| 2020 | 1,573 | 247 | None | 22% | $314,758 |
| 2019 | 1,938 | 246 | None | None | $246,894 |
| 2018 | 2,098 | 279 | 1% (11) | None | $293,805 |
| 2017 | 2,000 | 277 | 1% (18) | None | $308,489 |
| 2016 | 1,924 | 233 | 1% (11) | None | $436,236 |
| 2015 | 2,050 | 238 | 1% (20) | None | $428,940 |
| 2014 | 2,190 | 231 | 2% (43) | None | $370,183 |
| 2013 | 2,628 | 247 | 3% (80) | None | $397,261 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Farxiga | 47 | $62,236 | $1,324 |
| Sevelamer Carbonate | 58 | $30,476 | $525 |
| Lokelma | 29 | $27,668 | $954 |
| Renvela | 12 | $23,007 | $1,917 |
| Kerendia | 12 | $21,788 | $1,816 |
| Auryxia | 11 | $15,013 | $1,365 |
| Febuxostat | 21 | $8,690 | $414 |
| Clonidine | 32 | $4,683 | $146 |
| Calcium Acetate | 45 | $3,179 | $71 |
| Losartan | 110 | $2,751 | $25 |
| Tacrolimus | 15 | $2,526 | $168 |
| Bumetanide | 53 | $2,511 | $47 |
| Calcitriol | 113 | $2,450 | $22 |
| Telmisartan | 26 | $2,227 | $86 |
| Nifedipine Er | 23 | $1,952 | $85 |
| Hydralazine | 48 | $1,806 | $38 |
| Potassium Chloride | 43 | $1,633 | $38 |
| Chlorthalidone | 43 | $1,473 | $34 |
| Furosemide | 130 | $1,396 | $11 |
| Irbesartan | 30 | $1,322 | $44 |
| Carvedilol | 45 | $1,238 | $28 |
| Amlodipine Besylate | 69 | $1,120 | $16 |
| Lisinopril | 46 | $1,029 | $22 |
| Allopurinol | 54 | $962 | $18 |
| Valsartan | 16 | $808 | $50 |
| Tamsulosin | 29 | $779 | $27 |
| Sodium Polystyrene Sulfonate | 14 | $645 | $46 |
| Indapamide | 21 | $637 | $30 |
| Metolazone | 14 | $578 | $41 |
| Spironolactone | 17 | $409 | $24 |
| Clonidine | 14 | $389 | $28 |
| Prednisone | 26 | $325 | $12 |
| Gabapentin | 16 | $311 | $19 |
| Famotidine | 24 | $290 | $12 |
| Metoprolol | 14 | $211 | $15 |
| Metoprolol | 11 | $151 | $14 |
2022: 32 drugs
| Lanthanum Carbonate | 26 | $42,099 | $1,619 |
| Sevelamer Carbonate | 58 | $29,433 | $507 |
| Lokelma | 21 | $21,236 | $1,011 |
| Farxiga | 13 | $18,525 | $1,425 |
| Renvela | 11 | $16,774 | $1,525 |
| Auryxia | 16 | $16,486 | $1,030 |
| Rayaldee | 11 | $12,821 | $1,166 |
| Calcium Acetate | 58 | $8,098 | $140 |
| Febuxostat | 19 | $7,134 | $375 |
| Clonidine | 28 | $5,264 | $188 |
| Sps | 11 | $3,704 | $337 |
| Bumetanide | 37 | $3,139 | $85 |
| Nifedipine Er | 23 | $2,675 | $116 |
| Calcitriol | 121 | $2,519 | $21 |
| Potassium Chloride | 35 | $2,009 | $57 |
| Hydralazine | 45 | $1,770 | $39 |
| Colchicine | 22 | $1,735 | $79 |
| Losartan | 111 | $1,653 | $15 |
| Telmisartan | 18 | $1,646 | $91 |
| Furosemide | 139 | $1,070 | $8 |
| Carvedilol | 53 | $928 | $18 |
| Allopurinol | 57 | $852 | $15 |
| Midodrine | 15 | $851 | $57 |
| Clonidine | 29 | $722 | $25 |
| Chlorthalidone | 20 | $670 | $33 |
| Metolazone | 22 | $588 | $27 |
| Lisinopril | 46 | $506 | $11 |
| Gabapentin | 19 | $478 | $25 |
| Amlodipine Besylate | 57 | $472 | $8 |
| Doxazosin Mesylate | 13 | $464 | $36 |
| Tamsulosin | 25 | $324 | $13 |
| Spironolactone | 11 | $100 | $9 |
2021: 35 drugs
| Auryxia | 20 | $32,849 | $1,642 |
| Lokelma | 29 | $31,466 | $1,085 |
| Lanthanum Carbonate | 18 | $27,629 | $1,535 |
| Sevelamer Carbonate | 52 | $19,252 | $370 |
| Rayaldee | 12 | $16,774 | $1,398 |
| Calcium Acetate | 63 | $8,295 | $132 |
| Sps | 31 | $5,071 | $164 |
| Clonidine | 30 | $4,105 | $137 |
| Bumetanide | 47 | $3,966 | $84 |
| Febuxostat | 18 | $3,864 | $215 |
| Potassium Chloride | 40 | $3,200 | $80 |
| Colchicine | 14 | $2,077 | $148 |
| Nifedipine Er | 18 | $1,934 | $107 |
| Calcitriol | 102 | $1,907 | $19 |
| Tacrolimus | 15 | $1,760 | $117 |
| Sodium Polystyrene Sulfonate | 24 | $1,401 | $58 |
| Hydralazine | 47 | $1,243 | $26 |
| Allopurinol | 69 | $1,203 | $17 |
| Metolazone | 24 | $1,106 | $46 |
| Lidocaine-Prilocaine | 18 | $919 | $51 |
| Losartan | 78 | $797 | $10 |
| Carvedilol | 62 | $777 | $13 |
| Gabapentin | 24 | $718 | $30 |
| Furosemide | 82 | $681 | $8 |
| Chlorthalidone | 16 | $611 | $38 |
| Amlodipine Besylate | 85 | $604 | $7 |
| Doxazosin Mesylate | 16 | $592 | $37 |
| Clonidine | 28 | $574 | $21 |
| Prednisone | 21 | $450 | $21 |
| Constulose | 12 | $357 | $30 |
| Lisinopril | 39 | $263 | $7 |
| Spironolactone | 21 | $261 | $12 |
| Tamsulosin | 21 | $253 | $12 |
| Omeprazole | 12 | $140 | $12 |
| Metoprolol | 11 | $113 | $10 |
2020: 41 drugs
| Auryxia | 41 | $77,461 | $1,889 |
| Velphoro | 15 | $53,636 | $3,576 |
| Lokelma | 48 | $32,004 | $667 |
| Lanthanum Carbonate | 24 | $23,648 | $985 |
| Renvela | 19 | $19,501 | $1,026 |
| Sevelamer Carbonate | 30 | $15,526 | $518 |
| Rayaldee | 13 | $14,478 | $1,114 |
| Febuxostat | 21 | $9,185 | $437 |
| Calcium Acetate | 58 | $6,385 | $110 |
| Clonidine | 25 | $4,392 | $176 |
| Potassium Chloride | 46 | $2,710 | $59 |
| Bumetanide | 40 | $2,532 | $63 |
| Calcitriol | 123 | $2,408 | $20 |
| Nifedipine Er | 18 | $1,859 | $103 |
| Sps | 11 | $1,696 | $154 |
| Colchicine | 12 | $1,312 | $109 |
| Clonidine | 52 | $1,211 | $23 |
| Allopurinol | 78 | $1,174 | $15 |
| Isosorbide Dinitrate | 13 | $1,087 | $84 |
| Tacrolimus | 18 | $1,058 | $59 |
| Hydralazine | 63 | $955 | $15 |
| Mycophenolate Mofetil | 12 | $878 | $73 |
| Metolazone | 16 | $828 | $52 |
| Chlorthalidone | 17 | $796 | $47 |
| Amlodipine Besylate | 118 | $717 | $6 |
| Furosemide | 98 | $679 | $7 |
| Midodrine | 11 | $654 | $59 |
| Losartan | 48 | $596 | $12 |
| Doxazosin Mesylate | 22 | $575 | $26 |
| Lidocaine-Prilocaine | 14 | $524 | $37 |
| Prednisone | 17 | $475 | $28 |
| Carvedilol | 58 | $368 | $6 |
| Spironolactone | 22 | $354 | $16 |
| Indapamide | 11 | $286 | $26 |
| Lisinopril | 25 | $267 | $11 |
| Tamsulosin | 20 | $260 | $13 |
| Metoprolol | 18 | $191 | $11 |
| Gabapentin | 25 | $139 | $6 |
| Amiloride | 11 | $133 | $12 |
| Trazodone | 11 | $49 | $4 |
| Simvastatin | 11 | $29 | $3 |
2019: 42 drugs
| Auryxia | 46 | $52,855 | $1,149 |
| Renvela | 20 | $27,289 | $1,364 |
| Veltassa | 25 | $20,387 | $815 |
| Rayaldee | 17 | $18,607 | $1,095 |
| Sevelamer Carbonate | 20 | $11,352 | $568 |
| Lanthanum Carbonate | 11 | $10,604 | $964 |
| Uloric | 12 | $9,005 | $750 |
| Lokelma | 24 | $7,849 | $327 |
| Clonidine | 34 | $7,327 | $215 |
| Eliquis | 13 | $5,836 | $449 |
| Calcitriol | 212 | $5,119 | $24 |
| Calcium Acetate | 57 | $4,153 | $73 |
| Colchicine | 20 | $3,561 | $178 |
| Tacrolimus | 20 | $3,405 | $170 |
| Potassium Chloride | 47 | $2,309 | $49 |
| Allopurinol | 132 | $2,028 | $15 |
| Doxazosin Mesylate | 39 | $1,860 | $48 |
| Isosorbide Dinitrate | 25 | $1,816 | $73 |
| Bumetanide | 25 | $1,684 | $67 |
| Hydralazine | 73 | $1,656 | $23 |
| Nifedipine Er | 14 | $1,646 | $118 |
| Metolazone | 28 | $1,604 | $57 |
| Clonidine | 77 | $1,509 | $20 |
| Sps | 18 | $1,338 | $74 |
| Midodrine | 18 | $1,183 | $66 |
| Furosemide | 131 | $1,036 | $8 |
| Amlodipine Besylate | 141 | $982 | $7 |
| Chlorthalidone | 19 | $959 | $50 |
| Telmisartan | 14 | $654 | $47 |
| Carvedilol | 58 | $635 | $11 |
| Lidocaine-Prilocaine | 19 | $577 | $30 |
| Spironolactone | 29 | $553 | $19 |
| Losartan | 39 | $497 | $13 |
| Gentamicin Sulfate | 11 | $431 | $39 |
| Torsemide | 20 | $401 | $20 |
| Tamsulosin | 22 | $384 | $17 |
| Prednisone | 17 | $343 | $20 |
| Lisinopril | 32 | $332 | $10 |
| Metoprolol | 15 | $286 | $19 |
| Ranitidine | 16 | $266 | $17 |
| Metoprolol | 32 | $186 | $6 |
| Gabapentin | 17 | $83 | $5 |
2018: 43 drugs
| Renvela | 62 | $85,319 | $1,376 |
| Auryxia | 51 | $58,238 | $1,142 |
| Sevelamer Carbonate | 36 | $27,907 | $775 |
| Uloric | 25 | $15,512 | $620 |
| Calcitriol | 211 | $5,094 | $24 |
| Clonidine | 15 | $4,855 | $324 |
| Eliquis | 12 | $4,341 | $362 |
| Calcium Acetate | 51 | $3,295 | $65 |
| Doxazosin Mesylate | 50 | $2,541 | $51 |
| Metolazone | 57 | $2,439 | $43 |
| Isosorbide Dinitrate | 23 | $1,749 | $76 |
| Allopurinol | 127 | $1,606 | $13 |
| Potassium Chloride | 29 | $1,445 | $50 |
| Hydralazine | 53 | $1,094 | $21 |
| Sodium Polystyrene Sulfonate | 16 | $1,020 | $64 |
| Nifedipine Er | 12 | $1,010 | $84 |
| Clonidine | 88 | $1,001 | $11 |
| Midodrine | 18 | $991 | $55 |
| Bumetanide | 16 | $941 | $59 |
| Triazolam | 14 | $939 | $67 |
| Amlodipine Besylate | 134 | $785 | $6 |
| Sps | 21 | $707 | $34 |
| Lisinopril | 80 | $706 | $9 |
| Chlorthalidone | 15 | $698 | $47 |
| Tamsulosin | 31 | $644 | $21 |
| Losartan | 64 | $613 | $10 |
| Furosemide | 103 | $578 | $6 |
| Lidocaine-Prilocaine | 17 | $542 | $32 |
| Torsemide | 21 | $516 | $25 |
| Metoprolol | 13 | $497 | $38 |
| Carvedilol | 62 | $467 | $8 |
| Spironolactone | 31 | $444 | $14 |
| Kionex | 16 | $396 | $25 |
| Prednisone | 19 | $280 | $15 |
| Atorvastatin | 11 | $230 | $21 |
| Metoprolol | 37 | $180 | $5 |
| Gabapentin | 18 | $156 | $9 |
| Ranitidine | 21 | $152 | $7 |
| Indapamide | 12 | $147 | $12 |
| Ondansetron | 14 | $146 | $10 |
| Clopidogrel | 12 | $82 | $7 |
| Simvastatin | 14 | $75 | $5 |
| Omeprazole | 12 | $73 | $6 |
2017: 38 drugs
| Renvela | 68 | $93,484 | $1,375 |
| Sensipar | 56 | $89,288 | $1,594 |
| Auryxia | 31 | $41,764 | $1,347 |
| Calcitriol | 255 | $5,918 | $23 |
| Clonidine | 15 | $4,610 | $307 |
| Potassium Chloride | 46 | $3,919 | $85 |
| Calcium Acetate | 29 | $2,899 | $100 |
| Metolazone | 51 | $2,244 | $44 |
| Bumetanide | 20 | $1,503 | $75 |
| Kionex | 30 | $1,238 | $41 |
| Allopurinol | 89 | $1,203 | $14 |
| Hydralazine | 69 | $1,141 | $17 |
| Doxazosin Mesylate | 31 | $1,129 | $36 |
| Isosorbide Dinitrate | 14 | $1,007 | $72 |
| Chlorthalidone | 20 | $888 | $44 |
| Amlodipine Besylate | 139 | $854 | $6 |
| Sodium Polystyrene Sulfonate | 16 | $831 | $52 |
| Metoprolol | 35 | $768 | $22 |
| Lisinopril | 94 | $752 | $8 |
| Furosemide | 138 | $654 | $5 |
| Midodrine | 16 | $645 | $40 |
| Torsemide | 26 | $548 | $21 |
| Spironolactone | 48 | $539 | $11 |
| Clonidine | 68 | $534 | $8 |
| Tamsulosin | 13 | $440 | $34 |
| Carvedilol | 65 | $435 | $7 |
| Indapamide | 17 | $422 | $25 |
| Felodipine Er | 11 | $291 | $26 |
| Prednisone | 22 | $290 | $13 |
| Atorvastatin | 25 | $262 | $10 |
| Losartan | 23 | $260 | $11 |
| Lidocaine-Prilocaine | 11 | $245 | $22 |
| Metoprolol | 26 | $159 | $6 |
| Omeprazole | 24 | $154 | $6 |
| Gabapentin | 14 | $130 | $9 |
| Simvastatin | 20 | $111 | $6 |
| Ranitidine | 18 | $96 | $5 |
| Benazepril | 14 | $75 | $5 |
2016: 37 drugs
| Renvela | 120 | $212,793 | $1,773 |
| Sensipar | 67 | $91,399 | $1,364 |
| Uloric | 30 | $20,106 | $670 |
| Fosrenol | 16 | $18,612 | $1,163 |
| Auryxia | 18 | $9,166 | $509 |
| Renagel | 13 | $8,130 | $625 |
| Calcitriol | 195 | $4,828 | $25 |
| Clonidine | 11 | $3,915 | $356 |
| Calcium Acetate | 37 | $3,484 | $94 |
| Potassium Chloride | 41 | $2,536 | $62 |
| Kionex | 33 | $1,445 | $44 |
| Metolazone | 41 | $1,366 | $33 |
| Chlorthalidone | 28 | $1,211 | $43 |
| Sps | 13 | $967 | $74 |
| Hydralazine | 68 | $796 | $12 |
| Indapamide | 37 | $769 | $21 |
| Allopurinol | 53 | $668 | $13 |
| Nifedipine Er | 20 | $626 | $31 |
| Torsemide | 38 | $622 | $16 |
| Clonidine | 49 | $513 | $10 |
| Amlodipine Besylate | 108 | $460 | $4 |
| Furosemide | 100 | $453 | $5 |
| Isosorbide Mononitrate Er | 17 | $409 | $24 |
| Metoprolol | 19 | $366 | $19 |
| Atorvastatin | 24 | $354 | $15 |
| Spironolactone | 46 | $346 | $8 |
| Lisinopril | 73 | $336 | $5 |
| Levothyroxine | 31 | $322 | $10 |
| Carvedilol | 47 | $312 | $7 |
| Losartan | 25 | $288 | $12 |
| Prednisone | 22 | $284 | $13 |
| Minoxidil | 14 | $190 | $14 |
| Clopidogrel | 16 | $131 | $8 |
| Simvastatin | 39 | $127 | $3 |
| Metoprolol | 33 | $117 | $4 |
| Omeprazole | 17 | $104 | $6 |
| Ranitidine | 14 | $28 | $2 |
2015: 46 drugs
| Renvela | 148 | $210,398 | $1,422 |
| Sensipar | 60 | $65,839 | $1,097 |
| Fosrenol | 21 | $27,922 | $1,330 |
| Uloric | 31 | $11,062 | $357 |
| Renagel | 12 | $10,293 | $858 |
| Paricalcitol | 20 | $10,269 | $513 |
| Calcium Acetate | 87 | $6,733 | $77 |
| Calcitriol | 187 | $4,203 | $22 |
| Onglyza | 11 | $3,699 | $336 |
| Clonidine | 16 | $3,560 | $222 |
| Kionex | 46 | $2,132 | $46 |
| Chlorthalidone | 49 | $1,968 | $40 |
| Metolazone | 44 | $1,802 | $41 |
| Tolterodine | 14 | $1,525 | $109 |
| Sps | 18 | $1,493 | $83 |
| Isosorbide Dinitrate | 14 | $1,165 | $83 |
| Allopurinol | 96 | $870 | $9 |
| Nifedipine Er | 18 | $771 | $43 |
| Valsartan | 11 | $650 | $59 |
| Labetalol | 13 | $624 | $48 |
| Clonidine | 63 | $602 | $10 |
| Minoxidil | 24 | $491 | $20 |
| Isosorbide Mononitrate Er | 33 | $483 | $15 |
| Hydralazine | 53 | $478 | $9 |
| Felodipine Er | 13 | $473 | $36 |
| Lidocaine-Prilocaine | 14 | $453 | $32 |
| Amlodipine Besylate | 90 | $425 | $5 |
| Furosemide | 95 | $419 | $4 |
| Potassium Chloride | 19 | $401 | $21 |
| Lisinopril | 74 | $389 | $5 |
| Metoprolol | 69 | $294 | $4 |
| Torsemide | 20 | $273 | $14 |
| Metoprolol | 12 | $271 | $23 |
| Carvedilol | 57 | $270 | $5 |
| Prednisone | 19 | $242 | $13 |
| Indapamide | 11 | $226 | $21 |
| Losartan | 28 | $211 | $8 |
| Levothyroxine | 13 | $163 | $13 |
| Glipizide Er | 13 | $144 | $11 |
| Simvastatin | 23 | $128 | $6 |
| Hydrocodone-Acetaminophen | 16 | $119 | $7 |
| Lovastatin | 14 | $117 | $8 |
| Omeprazole | 14 | $100 | $7 |
| Spironolactone | 21 | $92 | $4 |
| Famotidine | 15 | $85 | $6 |
| Glipizide | 30 | $76 | $3 |
2014: 52 drugs
| Renvela | 147 | $144,401 | $982 |
| Sensipar | 84 | $79,854 | $951 |
| Fosrenol | 39 | $41,218 | $1,057 |
| Paricalcitol | 23 | $12,440 | $541 |
| Sevelamer Carbonate | 17 | $10,561 | $621 |
| Calcium Acetate | 54 | $7,700 | $143 |
| Diovan | 25 | $6,317 | $253 |
| Clonidine | 25 | $5,663 | $227 |
| Uloric | 21 | $4,795 | $228 |
| Calcitriol | 139 | $3,881 | $28 |
| Mycophenolate Mofetil | 15 | $1,675 | $112 |
| Nifedipine Er | 27 | $1,316 | $49 |
| Hydralazine | 53 | $1,228 | $23 |
| Labetalol | 23 | $1,220 | $53 |
| Metolazone | 32 | $1,173 | $37 |
| Clobetasol Propionate | 12 | $1,077 | $90 |
| Kionex | 30 | $1,039 | $35 |
| Sps | 16 | $885 | $55 |
| Felodipine Er | 19 | $853 | $45 |
| Isosorbide Mononitrate Er | 41 | $755 | $18 |
| Benazepril-Hydrochlorothiazide | 12 | $736 | $61 |
| Proair Hfa | 14 | $695 | $50 |
| Clonidine | 51 | $674 | $13 |
| Losartan | 42 | $662 | $16 |
| Minoxidil | 44 | $644 | $15 |
| Carvedilol | 75 | $590 | $8 |
| Chlorthalidone | 22 | $543 | $25 |
| Lisinopril | 119 | $520 | $4 |
| Allopurinol | 82 | $501 | $6 |
| Furosemide | 109 | $486 | $4 |
| Amlodipine Besylate | 78 | $471 | $6 |
| Metoprolol | 13 | $450 | $35 |
| Omeprazole | 31 | $385 | $12 |
| Metoprolol | 69 | $319 | $5 |
| Levothyroxine | 22 | $292 | $13 |
| Prednisone | 17 | $291 | $17 |
| Finasteride | 21 | $274 | $13 |
| Azathioprine | 12 | $267 | $22 |
| Torsemide | 14 | $243 | $17 |
| Potassium Chloride | 14 | $225 | $16 |
| Hydrocodone-Acetaminophen | 17 | $222 | $13 |
| Gabapentin | 27 | $215 | $8 |
| Glipizide | 30 | $214 | $7 |
| Megestrol Acetate | 12 | $184 | $15 |
| Lovastatin | 12 | $144 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $136 | $10 |
| Famotidine | 19 | $125 | $7 |
| Hydrochlorothiazide | 15 | $96 | $6 |
| Acetaminophen-Codeine | 18 | $93 | $5 |
| Ranitidine | 12 | $76 | $6 |
| Simvastatin | 11 | $73 | $7 |
| Alprazolam | 11 | $70 | $6 |
2013: 56 drugs
| Renvela | 177 | $143,932 | $813 |
| Sensipar | 122 | $87,510 | $717 |
| Fosrenol | 75 | $71,341 | $951 |
| Zemplar | 36 | $17,158 | $477 |
| Calcium Acetate | 76 | $11,988 | $158 |
| Diovan | 24 | $9,832 | $410 |
| Uloric | 18 | $3,948 | $219 |
| Calcitriol | 101 | $3,069 | $30 |
| Lyrica | 13 | $2,597 | $200 |
| Benicar | 14 | $2,206 | $158 |
| Metoprolol | 40 | $2,116 | $53 |
| Clonidine | 12 | $1,920 | $160 |
| Nifedipine Er | 37 | $1,741 | $47 |
| Felodipine Er | 17 | $1,122 | $66 |
| Losartan | 67 | $1,113 | $17 |
| Kionex | 16 | $1,001 | $63 |
| Labetalol | 25 | $998 | $40 |
| Hydralazine | 43 | $960 | $22 |
| Clonidine | 73 | $928 | $13 |
| Carvedilol | 79 | $846 | $11 |
| Lisinopril | 152 | $821 | $5 |
| Proair Hfa | 17 | $796 | $47 |
| Omeprazole | 46 | $745 | $16 |
| Furosemide | 170 | $736 | $4 |
| Diltiazem Er | 12 | $681 | $57 |
| Isosorbide Mononitrate Er | 40 | $627 | $16 |
| Metolazone | 32 | $593 | $19 |
| Losartan-Hydrochlorothiazide | 26 | $556 | $21 |
| Minoxidil | 38 | $527 | $14 |
| Chlorthalidone | 24 | $507 | $21 |
| Megestrol Acetate | 29 | $486 | $17 |
| Allopurinol | 79 | $421 | $5 |
| Finasteride | 25 | $413 | $17 |
| Hydrocodone-Acetaminophen | 57 | $411 | $7 |
| Amlodipine Besylate | 58 | $369 | $6 |
| Metoprolol | 58 | $351 | $6 |
| Levothyroxine | 24 | $274 | $11 |
| Polyethylene Glycol 3350 | 11 | $240 | $22 |
| Hydrochlorothiazide | 37 | $240 | $6 |
| Sertraline | 14 | $229 | $16 |
| Indapamide | 24 | $212 | $9 |
| Bumetanide | 17 | $185 | $11 |
| Gabapentin | 18 | $180 | $10 |
| Glipizide | 29 | $164 | $6 |
| Simvastatin | 24 | $163 | $7 |
| Zolpidem | 28 | $145 | $5 |
| Mupirocin | 12 | $137 | $11 |
| Prednisone | 20 | $137 | $7 |
| Lovastatin | 13 | $116 | $9 |
| Warfarin | 15 | $113 | $8 |
| Pantoprazole | 13 | $103 | $8 |
| Levofloxacin | 12 | $92 | $8 |
| Acetaminophen-Codeine | 12 | $69 | $6 |
| Ciprofloxacin | 17 | $67 | $4 |
| Ranitidine | 12 | $57 | $5 |
| Diazepam | 11 | $25 | $2 |
Money from drug and device companies
$464 in 2025
| 2025 | 6 | 15 | None | $464 |
| 2024 | 5 | 12 | $1,950 | $2,916 |
| 2023 | 3 | 18 | $6,222 | $6,710 |
| 2022 | 1 | 8 | $2,700 | $3,587 |
| 2021 | 3 | 17 | $16,540 | $17,574 |
| 2020 | 1 | 10 | $9,100 | $9,375 |
| 2019 | 1 | 12 | $8,400 | $10,297 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $173 | 2 payments
|
| Amgen | Krystexxa | $152 | 8 payments
|
| Novartis Pharmaceuticals | Fabhalta | $66 | 2 payments
|
| Vantive US Healthcare | Renal - Pd | $27 | 1 payment
|
| GlaxoSmithKline | Benlysta | $27 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $19 | 1 payment
|
See all 15 published payments
| Amgen | Meals · 2025-10-24 | Krystexxa | $11 |
| Vantive US Healthcare | Meals · 2025-10-10 | Renal - Pd | $27 |
| OPKO Pharmaceuticals | Education · 2025-10-10 | Rayaldee | $19 |
| Amgen | Meals · 2025-10-01 | Krystexxa | $9 |
| Novartis Pharmaceuticals | Meals · 2025-09-24 | Fabhalta | $52 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Fabhalta | $14 |
| Amgen | Meals · 2025-08-04 | Krystexxa | $13 |
| GlaxoSmithKline | Meals · 2025-07-28 | Benlysta | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-15 | Jardiance | $52 |
| Amgen | Meals · 2025-06-04 | Krystexxa | $13 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-29 | Jardiance | $121 |
| Amgen | Meals · 2025-04-11 | Krystexxa | $17 |
| Amgen | Meals · 2025-04-06 | Krystexxa | $35 |
| Amgen | Meals · 2025-01-28 | Krystexxa | $17 |
| Amgen | Meals · 2025-01-23 | Krystexxa | $37 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,916
| AstraZeneca Pharmaceuticals LP | Lokelma | $2,072 | 3 payments
|
| Travere Therapeutics | None | $379 | 3 payments
|
| Novartis Pharmaceuticals | Fabhalta | $228 | 2 payments
|
| Amgen | Krystexxa | $212 | 3 payments
|
| Akebia Therapeutics | Vafseo | $25 | 1 payment
|
2023: $6,710
| Bayer Healthcare Pharmaceuticals | Kerendia | $6,369 | 6 payments
|
| Travere Therapeutics | None | $328 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $13 | 1 payment
|
2022: $3,587
| Travere Therapeutics | None | $3,587 | 8 payments
|
2021: $17,574
| Bayer HealthCare Pharmaceuticals | Kerendia | $14,612 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $2,958 | 5 payments
|
| Medtronic | Ellipsys | $4 | 1 payment
|
2020: $9,375
| AstraZeneca Pharmaceuticals LP | Lokelma | $9,375 | 10 payments
|
2019: $10,297
| AstraZeneca Pharmaceuticals LP | Lokelma | $10,297 | 12 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Quanta Dialysis Technologies Inc · Quanta Homerun · 2023 | This clinician | $41,738 |
| Medtronic Vascular, Inc. · In.Pact Av Access · 2019 | Their institution | $10,786 |
| Janssen Research & Development, LLC · A Randomized Double Blind, Placebo Group, Two-Arm, Multicenter Study To Assess Efficacy of Canagliflozin on End Stage Kidney Disease and Vascular Death in Subjects With Type 2 Diabetes Mellitus and Nephropathy · 2019 | Their institution | $5,850 |
| Quanta Dialysis Technologies Inc · Quanta Homerun · 2022 | This clinician | $3,831 |
| Bard Peripheral Vascular, Inc. · Aveva Bpv15001 · 2019 | Their institution | $1,240 |
| Medtronic Vascular, Inc. · In.Pact Av Access · 2020 | Their institution | $1,231 |
| Medtronic, Inc. · In.Pact Av Access · 2021 | Their institution | $150 |
Professional record
- NPI
- 1780608901
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0015060
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 1111 Exposition Blvd Ste 300, Sacramento, CA, 95815
- NPI first listed
- 2006-07-27
- NPI last updated
- 2026-09-08
- NPI record certified
- 2026-09-08
This is when the NPI record was last certified, not a medical board exam.